S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.49 USD -6.93% Market Closed
Market Cap: 233.2m USD

Wall Street
Price Targets

SOPH Price Targets Summary
Sophia Genetics SA

Wall Street analysts forecast SOPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOPH is 6.94 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

Lowest
Price Target
5.05 USD
45% Upside
Average
Price Target
6.94 USD
99% Upside
Highest
Price Target
11.55 USD
231% Upside
Sophia Genetics SA Competitors:
Price Targets
OPRX
OPTIMIZERx Corp
30% Upside
4483
JMDC Inc
26% Upside
300253
Winning Health Technology Group Co Ltd
19% Upside
OMCL
Omnicell Inc
59% Upside
BMT
Beamtree Holdings Ltd
164% Upside
OMDA
Omda AS
12% Downside
INSP
Inspire Medical Systems Inc
70% Upside
ALC
Alcidion Group Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Sophia Genetics SA

For the last 4 years the compound annual growth rate for Sophia Genetics SA's revenue is 23%. The projected CAGR for the next 3 years is 22%.

23%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sophia Genetics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Sophia Genetics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SOPH's stock price target?
Price Target
6.94 USD

According to Wall Street analysts, the average 1-year price target for SOPH is 6.94 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

What is Sophia Genetics SA's Revenue forecast?
Projected CAGR
22%

For the last 4 years the compound annual growth rate for Sophia Genetics SA's revenue is 23%. The projected CAGR for the next 3 years is 22%.

Back to Top